Association of Plasma Uremic Solute Levels with Residual Kidney Function in Children on Peritoneal Dialysis

Lakshmi L Ganesan1,2, Frank J O'Brien3, Tammy L Sirich4,5

  • 1Department of Pediatrics, Loma Linda University School of Medicine, Loma Linda, California.

Insights

Residual kidney function in pediatric peritoneal dialysis patients lowers uremic solute levels. This preservation of kidney function aids in managing solute concentrations, improving patient health outcomes.

Area of Science:

  • Nephrology
  • Pediatric Dialysis
  • Metabolomics

Background:

  • Residual native kidney function offers significant health benefits for patients undergoing dialysis.
  • It aids in managing fluid balance, electrolyte levels, and reducing the buildup of toxins.
  • This study focuses on the role of residual kidney function in pediatric patients on peritoneal dialysis.

Purpose of the Study:

  • To investigate the association between residual kidney function and plasma concentrations of uremic solutes in pediatric patients on peritoneal dialysis.
  • To determine if preserving kidney function impacts the levels of various toxins in the blood.

Main Methods:

  • Analyzed plasma samples from 29 pediatric patients on peritoneal dialysis (13 without, 10 with residual kidney function).
  • Utilized untargeted mass spectrometry-based metabolomics to compare plasma solute profiles.
  • Measured dialytic and residual clearances of specific solutes using chemical standard assays.

Main Results:

  • Patients with residual kidney function had significantly lower plasma levels of 59 out of 256 measured uremic solutes compared to those without.
  • Average uremic solute levels were 64% lower in patients with residual kidney function, even with similar dialysis efficacy (Kt/V urea).
  • Residual kidney function contributed a greater proportion to the clearance of non-urea solutes than urea itself.

Conclusions:

  • Pediatric peritoneal dialysis patients with residual kidney function exhibit lower concentrations of numerous uremic solutes.
  • Preserving residual kidney function is crucial for effective toxin management in this population.
  • These findings highlight the importance of maintaining native kidney function during dialysis treatment.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
223
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
160
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
94
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
36
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
39
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
767